BMP2 Antikörper (AA 283-396)
Kurzübersicht für BMP2 Antikörper (AA 283-396) (ABIN513751)
Target
Alle BMP2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Bindungsspezifität
- AA 283-396
- 
                                            Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant BMP2.
- 
                                            Sequenz
- QAKHKQRKRL KSSCKRHPLY VDFSDVGWND WIVAPPGYHA FYCHGECPFP LADHLNSTNH AIVQTLVNSV NSKIPKACCV PTELSAISML YLDENEKVVL KNYQDMVVEG CGCR
- 
                                            Kreuzreaktivität
- Human
- 
                                            Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- 
                                            Immunogen
- BMP2 (NP_001191, 283 a.a. ~ 396 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- 
                                            Isotyp
- IgG2a
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Buffer
- In 1x PBS, pH 7.4
- 
                                            Handhabung
- Aliquot to avoid repeated freezing and thawing.
- 
                                            Lagerung
- -20 °C
- 
                                            Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
 
- 
                                            
- 
    - 
                                            : "Biomechanical analysis of engineered bone with anti-BMP2 antibody immobilized on different scaffolds."    in: Journal of biomedical materials research. Part B, Applied biomaterials, (2015)         (PubMed).        
 : "Immobilization of murine anti-BMP-2 monoclonal antibody on various biomaterials for bone tissue engineering." in: BioMed research international, Vol. 2014, pp. 940860, (2014) (PubMed).
 : "Antibody-mediated osseous regeneration: the early events in the healing response." in: Tissue engineering. Part A, Vol. 19, Issue 9-10, pp. 1165-74, (2013) (PubMed).
 : "Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering." in: Biomaterials, Vol. 34, Issue 28, pp. 6572-9, (2013) (PubMed).
 : "Functionalization of scaffolds with chimeric anti-BMP-2 monoclonal antibodies for osseous regeneration." in: Biomaterials, Vol. 34, Issue 38, pp. 10191-8, (2013) (PubMed).
 : "Antibody-mediated osseous regeneration: a novel strategy for bioengineering bone by immobilized anti-bone morphogenetic protein-2 antibodies." in: Tissue engineering. Part A, Vol. 17, Issue 23-24, pp. 2911-8, (2011) (PubMed).
 
 
- 
                                            : "Biomechanical analysis of engineered bone with anti-BMP2 antibody immobilized on different scaffolds."    in: Journal of biomedical materials research. Part B, Applied biomaterials, (2015)         (PubMed).        
- 
    - BMP2 (Bone Morphogenetic Protein 2 (BMP2))
- 
                                            Andere Bezeichnung
- BMP2
- 
                                            Hintergrund
- 
                        Full Gene Name: bone morphogenetic protein 2
 Synonyms: BMP2A
- 
                                            Gen-ID
- 650
- 
                                            NCBI Accession
- NM_001200
- 
                                            Pathways
- Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, Regulation of Muscle Cell Differentiation, Growth Factor Binding, Positive Regulation of fat Cell Differentiation
 Target
- 
                    
 
                                     
                                     
                                    